{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:50:32Z","timestamp":1772895032472,"version":"3.50.1"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"36","license":[{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,5]]},"abstract":"<jats:p>\n                    The purpose of this article was to study the distribution of left ventricular hypertrophy (LVH) and cardiac valve calcification (CVC), relevant factors, and the relationship of LVH and CVC with survival in maintenance hemodialysis (MHD) patients. A total of 281 MHD patients were included in this retrospective and follow-up study. Echocardiography measurements were performed to evaluate the left ventricular structure and cardiac valve. Left ventricular mass (LVM), LVM index, relative wall thickness, and prevalence of LVH and CVC were calculated. Factors related to LVH and CVC and patients\u2019 death risk were analyzed. The primary outcome was death. The prevalence of LVH in this study was 50.53% (142 patients). Concentric hypertrophy, concentric remodeling, and eccentric hypertrophy were found in 39.86%, 25.98%, and 10.68% of patients, respectively. Factors associated with LVH included systolic pressure, CVC, hemoglobin, and calcium carbonate in a multivariate logistic regression model (all\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;.01). The log-rank\n                    <jats:italic toggle=\"yes\">\u03c7<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    , which were 10.957, 12.668, 10.181, and 8.474 at 6, 12, 18, and 24 months follow-up, respectively, in the Kaplan\u2013Meier model demonstrated the lower survival rates in patients with LVH than in those without (all\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;.01). The prevalence of CVC was 60.14% (169 patients). Aortic valve calcification, mitral valve calcification, or both were found in 54.09%, 33.10%, and 27.05% of patients, respectively. In a multivariate logistic regression model, the factors associated with CVC were coronary heart disease, LVH, calcium, age, dialysis age, and diastolic pressure (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;.05). In COX proportional hazard model, LVH resulted as an independent risk factor to all-cause death; the adjusted HR was 11.045, 4.382, 3.075, and 2.586 at 6, 12, 18, and 24 months follow-up, respectively (all\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;.05). In MHD patients, LVH and CVC were highly prevalent, and LVH resulted as an independent risk factor for all-cause death.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000044181","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T18:07:35Z","timestamp":1757354855000},"page":"e44181","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Left ventricular hypertrophy and cardiac valve calcification and their impacts on survival in maintenance hemodialysis patients: A retrospective cohort study"],"prefix":"10.1097","volume":"104","author":[{"given":"Xiaochun","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Critical Care Medicine, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiping","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1576-3118","authenticated-orcid":false,"given":"Fuhua","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R3-20251029","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0140-6736(16)30508-6","article-title":"The heart and vascular system in dialysis.","volume":"388","author":"Wanner","year":"2016","journal-title":"Lancet (Lond)"},{"key":"R4-20251029","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/s41598-020-79531-4","article-title":"Baseline data report of the China dialysis outcomes and practice pattern study (DOPPS).","volume":"11","author":"Zhao","year":"2021","journal-title":"Sci Rep"},{"key":"R5-20251029","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.nephro.2017.06.001","article-title":"Left ventricular hypertrophy in chronic hemodialysis patients at CNHU-HKM of Cotonou.","volume":"14","author":"Vigan","year":"2018","journal-title":"Nephrol Ther"},{"key":"R6-20251029","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/08860220801964178","article-title":"The prevalence of left ventricular hypertrophy in Chinese hemodialysis patients is higher than that in peritoneal dialysis patients.","volume":"30","author":"Tian","year":"2008","journal-title":"Ren Fail"},{"key":"R7-20251029","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/MNH.0000000000000067","article-title":"Is left ventricular hypertrophy a modifiable risk factor in end-stage renal disease.","volume":"23","author":"Charytan","year":"2014","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R8-20251029","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1053\/j.ajkd.2016.05.025","article-title":"Intensive hemodialysis, left ventricular hypertrophy, and cardiovascular disease.","volume":"68","author":"McCullough","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"R9-20251029","doi-asserted-by":"crossref","first-page":"211","DOI":"10.5301\/JN.2011.8446","article-title":"Cardiac valve calcification is a marker of vascular disease in prevalent hemodialysis patients.","volume":"25","author":"Bellasi","year":"2012","journal-title":"J Nephrol"},{"key":"R10-20251029","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s11255-020-02590-z","article-title":"Malnutrition as a risk factor for cardiac valve calcification in patients under maintenance dialysis: a cross-sectional study.","volume":"52","author":"Plytzanopoulou","year":"2020","journal-title":"Int Urol Nephrol"},{"key":"R11-20251029","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00380-017-0969-4","article-title":"Relationship between cardiac calcification and left ventricular hypertrophy in patients with chronic kidney disease at hemodialysis initiation.","volume":"32","author":"Kitamura","year":"2017","journal-title":"Heart Vessels"},{"key":"R12-20251029","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1097\/01.ASN.0000130566.69170.5E","article-title":"Development, prevention, and potential reversal of left ventricular hypertrophy in chronic kidney disease.","volume":"15","author":"McMahon","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R13-20251029","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jash.2012.01.004","article-title":"Left ventricular hypertrophy by electrocardiography and echocardiography in the African American Study of Kidney Disease Cohort Study.","volume":"6","author":"Esquitin","year":"2012","journal-title":"J Am Soc Hypertens"},{"key":"R14-20251029","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.kint.2016.10.012","article-title":"Reappraisal in two European cohorts of the prognostic power of left ventricular mass index in chronic kidney failure.","volume":"91","author":"Tripepi","year":"2017","journal-title":"Kidney Int"},{"key":"R15-20251029","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12872-018-0747-y","article-title":"Cardiac valve calcification and risk of cardiovascular or all-cause mortality in dialysis patients: a meta-analysis.","volume":"18","author":"Wang","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"key":"R16-20251029","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","article-title":"Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention.","volume":"382","author":"Gansevoort","year":"2013","journal-title":"Lancet (Lond)"},{"issue":"suppl_3","key":"R17-20251029","doi-asserted-by":"crossref","first-page":"iii28","DOI":"10.1093\/ndt\/gfy174","article-title":"Cardiovascular disease in dialysis patients.","volume":"33","author":"Cozzolino","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"R18-20251029","doi-asserted-by":"crossref","first-page":"e031476","DOI":"10.1136\/bmjopen-2019-031476","article-title":"Haemoglobin concentration and survival of haemodialysis patients before and after experiencing cardiovascular disease: a cohort study from Japanese dialysis outcomes and practice pattern study (J-DOPPS).","volume":"9","author":"Kido","year":"2019","journal-title":"BMJ Open"},{"key":"R19-20251029","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1053\/j.jrn.2019.07.006","article-title":"The efficacy of prebiotic, probiotic, and synbiotic supplementation in modulating gut-derived circulatory particles associated with cardiovascular disease in individuals receiving dialysis: a systematic review and meta-analysis of randomized controlled trials.","volume":"30","author":"March","year":"2020","journal-title":"J Ren Nutr"},{"key":"R20-20251029","first-page":"479","article-title":"Mortality and associated risk factors in dialysis patients with cardiovascular disease.","volume":"41","author":"Tong","year":"2016"},{"key":"R21-20251029","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/08860220500243296","article-title":"Cardiac valve calcifications and left ventricular hypertrophy in hemodialysis patients.","volume":"27","author":"Str\u00f3zecki","year":"2005","journal-title":"Ren Fail"},{"key":"R22-20251029","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/hdi.12644","article-title":"Left ventricular geometric patterns in end-stage kidney disease: determinants and course over time.","volume":"22","author":"Nub\u00e9","year":"2018","journal-title":"Hemodial Int"},{"key":"R23-20251029","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s11255-007-9317-4","article-title":"Relationship between aortic valve sclerosis and left ventricular hypertrophy in chronic haemodialysis patients.","volume":"40","author":"Turkmen","year":"2008","journal-title":"Int Urol Nephrol"},{"key":"R24-20251029","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9149(86)90771-X","article-title":"Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.","volume":"57","author":"Devereux","year":"1986","journal-title":"Am J Cardiol"},{"key":"R25-20251029","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0894-7317(89)80014-8","article-title":"Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms.","volume":"2","author":"Schiller","year":"1989","journal-title":"J Am Soc Echocardiogr"},{"key":"R26-20251029","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.metabol.2005.11.004","article-title":"Body surface area in normal-weight, overweight, and obese adults. A comparison study.","volume":"55","author":"Verbraecken","year":"2006","journal-title":"Metab Clin Exp"},{"key":"R27-20251029","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00004872-200306000-00001","article-title":"2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.","volume":"21","year":"2003","journal-title":"J Hypertens"},{"key":"R28-20251029","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1053\/j.ajkd.2017.07.019","article-title":"KDOQI US commentary on the 2017 KDIGO clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).","volume":"70","author":"Isakova","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"4 Suppl 3","key":"R29-20251029","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients.","volume":"45","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R30-20251029","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ejheart.2006.10.002","article-title":"Endogenous inhibitors of hypertrophy in concentric versus eccentric hypertrophy.","volume":"9","author":"Lemmens","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"R31-20251029","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1161\/01.HYP.0000121363.08252.a7","article-title":"Concentric or eccentric hypertrophy: how clinically relevant is the difference?","volume":"43","author":"de Simone","year":"2004","journal-title":"Hypertension"},{"key":"R32-20251029","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1681\/ASN.2009060631","article-title":"Left ventricular geometry predicts cardiovascular outcomes associated with anemia correction in CKD.","volume":"20","author":"Eckardt","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R33-20251029","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2215\/CJN.06980615","article-title":"Associations of left ventricular hypertrophy and geometry with adverse outcomes in patients with CKD and hypertension.","volume":"11","author":"Paoletti","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"R34-20251029","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.2215\/CJN.01140211","article-title":"All-cause mortality in hemodialysis patients with heart valve calcification.","volume":"6","author":"Raggi","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R35-20251029","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijcard.2012.06.081","article-title":"Aortic and mitral valvular calcification in patients undergoing hemodialysis for 10 years or more and their prognosis.","volume":"164","author":"Sone","year":"2013","journal-title":"Int J Cardiol"},{"key":"R36-20251029","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/01.ASN.0000038685.95946.83","article-title":"Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study.","volume":"14","author":"Wang","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R37-20251029","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2215\/CJN.03100509","article-title":"Is valvular calcification a part of the missing link between residual kidney function and cardiac hypertrophy in peritoneal dialysis patients?","volume":"4","author":"Wang","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R38-20251029","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1053\/j.ajkd.2016.03.418","article-title":"The validity of left ventricular mass as a surrogate end point for all-cause and cardiovascular mortality outcomes in people with CKD: a systematic review and meta-analysis.","volume":"68","author":"Badve","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"R39-20251029","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/ndt\/gfn685","article-title":"Aortic valvular calcification predicts restenosis after implantation of drug-eluting stents in patients on chronic haemodialysis.","volume":"24","author":"Ishii","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R40-20251029","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000507183","article-title":"Association between serum dickkopf-1 (DKK-1) glycoprotein and calcific deposits on cardiac valves and carotid intimal-medial thickness in hemodialysis patients.","volume":"10","author":"Younis","year":"2020","journal-title":"Cardiorenal Med"},{"key":"R41-20251029","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1159\/000336946","article-title":"The prevalence of hypertension, valve calcification and left ventricular hypertrophy and geometry in peritoneal dialysis patients.","volume":"35","author":"Yilmaz","year":"2012","journal-title":"Kidney Blood Press Res"},{"key":"R42-20251029","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic kidney disease.","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet (Lond)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044181","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:01:20Z","timestamp":1761750080000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":40,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044181","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,5]]},"assertion":[{"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}